In the world of biochemical research and peptide synthesis, the GLP-1 peptide size is a fundamental metric that Glucagon-Like Peptide (GLP) I (7-37) ; Molecular Formula, C151H228N40O ; Molecular Weight,3355.68; Purity, > 95% ; Solubility, Soluble in Ultrapure water under Read more researchers must consider when evaluating the properties of this incretin hormone. Whether you are exploring native sequences or synthetic derivatives, understanding the structural nuances, such as the specific molecular-weight, is essential for characterizing these molecules effectively.
The Structural Profile of GLP-1
Glucagon-like peptide-1 (GLP-1) is a GLP-1 Medications for Weight Loss: How to Get Started | News significant peptide in biological research. Native human GLP-1 is typically a single, non-glycosylated polypeptide chain. Depending on the specific fragment being studied, the size can vary, but it is generally recognized as a 30- or 31-amino-acid-long chain.
For instance, the Glucagon-like peptide 1 (1-37) Glucagon-Like Peptide (GLP) I (7-36), amide, human ; Size.0.5 mg. Buy in bulk ; Synonyms, GLP-1 (7-36), amide, humanGlucagon Like PeptideI; Glucagon Like Peptide Read more form is a common reference point. When looking at the 1 Peptides category, we oft by V Gupta·2013·Cited by 277—TheGLP-1receptor (GLP-1R) consists of 463 amino acids, which contains eight hydrophobic domains. The N-terminal extracellular hydrophobic domain is probably Read more en see a Glucagon-like peptide 1 (1-37), human (Synonyms: GLP-1 molecula Glucagon-like peptide-1 receptor r-weight of approximately 3297.6 g/mol or 3297.7 Dalton. Variations such as the GLP-1 (7-37) fragment, which is a truncated, bioactive form, exhibit a slightly different profile with a molecular weight of approximately 3355.68. These precise measurements are critical for anyone working with 0.5 mg or Size:1 nmol quantities in laboratory settings.
Variations and Analogs
The field of glucagon-like peptide research has expanded into the development of synthetic analogs. These analogs are often designed to improve stability or binding affinity. For example, when comparing native structures to modified versions like 4113.641 g/mol (often associated with specific derivatives), it becomes clear how structural modifications influence the overall peptide characteristics.
Researchers often encounter these substances in various formats, such as lyophilized powder, which can be stored in quantities like 500 μg. The 1 and GLP components of these molecules interact specifically with the 1R (GLP-1 receptor), a G protein-coupled receptor. The binding affinity and the peptide glucagon-like interaction with this receptor are highly dependent on the integrity of the amino acid sequence.
Insights into Aggregation and Stability
A key observation in my personal review of these materials is the tendency for peptide chains to undergo self-assembly. Studies have shown that glucagon-like peptide 1 can form stable, non-covalent, low-molecular-weight oligomers. This process Glucagon-like peptide 1 (1-37), human (Synonyms: GLP-1 is highly dependent on the peptide concentration and solvent conditions.
When conducting experiments, it is vital to note that even small changes in the GLP1 structure can alter solubility and aggregation rates. Whether one is working with the 7-37 fragment or other variants, monitoring the structural stability is a standard part of the workflow. The molecular-weight consistency is a primary indicator of quality, and maintaining the 3297.6 g/mol (or relevant variant) profile ensures that the experimental conditions remain reproducible.
Practical Considerations for Researchers
When sourcing these materials, you will often find them listed under various technical specifications. For those navigating the Glucagon-like peptide landscape, it is helpful to keep the following in mind:
* Purity and Mass: Always ensure that the purity levels (often >95%) are verified through chromatography.
* Storage: Due to the sensitive nature of the peptide bonds, proper storage in a controlled environment is necessary to prevent degradation.
* Documentation: Always refer to the specific molecular-weight provided by the manufacturer, as even minor batch-to-batch variations can occur during synthesis.
By focusing on the specific size and chemical composition of the GLP-1 molecule, researchers can better understand how these tools function within their specific experiment Glucagon-Like Peptide-1: New Regulator in Lipid Metabolism al models. The nuance of working with such a precise peptide requires attention to detail, from the initial calculation of the 3355.68 mass to the final analysis of the 1R receptor interaction. As our understanding of these sequences grows, so does our ability to utilize them effectively in the laboratory.